Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM110B Inhibitors

FAM110B inhibitors are a class of chemical compounds that specifically target and inhibit the function of the FAM110B protein, a member of the FAM110 family of proteins. These proteins are characterized by a highly conserved domain known as the FAM110 domain, which plays a critical role in various cellular processes, including the regulation of the cell cycle, mitosis, and microtubule organization. The inhibition of FAM110B disrupts its interactions with other proteins and its ability to regulate key cellular mechanisms. The structural biology of FAM110B inhibitors often involves interactions with the protein's active sites, blocking its function and potentially altering its localization within the cell. The development of these inhibitors typically involves extensive research into the protein's structure and function to identify key binding sites and develop molecules with high specificity and affinity. The design and synthesis of FAM110B inhibitors require a thorough understanding of the protein's role in cellular processes. The inhibitors are typically small molecules, peptides, or other chemical entities that are engineered to bind with high precision to the active or allosteric sites of FAM110B, thereby hindering its normal function. The binding of these inhibitors can induce conformational changes in the protein, affecting its interaction with other cellular components and leading to downstream effects on cell division and microtubule dynamics. Research into FAM110B inhibitors also involves studying their impact on cellular morphology and proliferation, with an emphasis on understanding how these inhibitors can modulate specific biochemical pathways. The characterization of these compounds involves a range of biochemical and biophysical techniques, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling, to elucidate the detailed mechanisms by which FAM110B inhibitors exert their effects at the molecular level.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A could potentially downregulate FAM110B by increasing the acetylation of histones around the gene's promoter region, leading to the suppression of its transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

If the FAM110B gene promoter is methylated, 5-Azacytidine could induce its demethylation, which may result in the silencing of FAM110B gene transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin may decrease FAM110B expression by inhibiting the mTOR pathway, which is often involved in controlling the translation and stability of mRNA transcripts.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Disulfiram could lead to the reduction of FAM110B expression by disrupting aldehyde dehydrogenase activity and altering intracellular signaling pathways.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic Acid might downregulate FAM110B by binding to retinoic acid receptors that repress the transcription of specific target genes, potentially including FAM110B.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyurea could decrease the expression of FAM110B by inhibiting ribonucleotide reductase, leading to a reduction in deoxyribonucleotide pools and DNA synthesis.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Methotrexate may downregulate FAM110B by inhibiting folate metabolism, which is crucial for the synthesis of thymidylate and purine nucleotides, thereby hindering DNA replication and gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 could reduce FAM110B expression by inhibiting phosphoinositide 3-kinases (PI3K), which may result in the downregulation of downstream gene transcription.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide might indirectly lead to a decrease in FAM110B levels by blocking peptide elongation during protein synthesis, which could destabilize mRNA transcripts.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate may suppress the transcription of FAM110B by inhibiting histone deacetylases, leading to hyperacetylation of histones and a closed chromatin state.